Welcome to LookChem.com Sign In|Join Free

CAS

  • or

301-15-5

Post Buying Request

301-15-5 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

301-15-5 Usage

Description

SYNTHALIN SULFATE is a hydrochloride compound resulting from the reaction of decamethylenediguanidine with 2 mol eq. of hydrogen chloride. It is a chemical entity with specific properties that can be utilized in various applications across different industries.

Uses

Used in Pharmaceutical Industry:
SYNTHALIN SULFATE is used as an active pharmaceutical ingredient for the development of medications targeting specific health conditions. Its unique chemical structure allows it to interact with biological systems, making it a potential candidate for therapeutic applications.
Used in Chemical Research:
In the field of chemical research, SYNTHALIN SULFATE serves as a subject of study for understanding its properties, reactivity, and potential interactions with other compounds. This research can lead to the discovery of new applications and uses for the compound.
Used in Material Science:
SYNTHALIN SULFATE can be utilized in material science as a component in the development of new materials with specific properties. Its chemical structure may contribute to the creation of materials with unique characteristics, such as improved stability, reactivity, or selectivity.
Used in Environmental Applications:
SYNTHALIN SULFATE may also find use in environmental applications, such as in the treatment of pollutants or the development of eco-friendly products. Its chemical properties could be harnessed to address environmental challenges and contribute to sustainability efforts.

Biological Activity

An effective non-competitive NMDA receptor antagonist in vivo and in vitro ; may bind to more than one site, one of which is the polyamine site.

Check Digit Verification of cas no

The CAS Registry Mumber 301-15-5 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 3,0 and 1 respectively; the second part has 2 digits, 1 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 301-15:
(5*3)+(4*0)+(3*1)+(2*1)+(1*5)=25
25 % 10 = 5
So 301-15-5 is a valid CAS Registry Number.

301-15-5SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name synthalin

1.2 Other means of identification

Product number -
Other names N,N'-1,10-DECANEDIYLBISGUANIDINE SULFATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:301-15-5 SDS

301-15-5Downstream Products

301-15-5Relevant articles and documents

Development of the first oral bioprecursors of bisalkylguanidine antimalarial drugs

Degardin, Mlissa,Wein, Sharon,Duckert, Jean-Frdric,Maynadier, Marjorie,Guy, Alexandre,Durand, Thierry,Escale, Roger,Vial, Henri,Vo-Hoang, Yen

supporting information, p. 300 - 304 (2014/04/03)

Plasmodium falciparum is responsible of the most severe form of malaria, and new targets and novel chemotherapeutic scaffolds are needed to fight emerging multidrug-resistant strains of this parasite. Bis-alkylguanidines have been designed to mimic choline, resulting in the inhibition of plasmodial de novo phosphatidylcholine biosynthesis. Despite potent in vitro antiplasmodial and in vivo antimalarial activities, a major drawback of these compounds for further clinical development is their low oral bioavailability. To solve this issue, various modulations were performed on bis-alkylguanidines. The introduction of N-disubstituents on the guanidino motif improved both in vitro and in vivo activities. On the other hand, in vivo pharmacological evaluation in a mouse model showed that the N-hydroxylated derivatives constitute the first oral bioprecursors in bis-alkylguanidine series. This study paves the way for bis-alkylguanidine-based oral antimalarial agents targeting plasmodial phospholipid metabolism.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 301-15-5